<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>45</Volume>
      <Issue>9</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>10</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Coffee and the Risk of Lymphoma: A Meta-analysis Article</title>
    <FirstPage>1126</FirstPage>
    <LastPage>1135</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Tianjie</FirstName>
        <LastName>HAN</LastName>
        <affiliation locale="en_US">Dept. of Hematology, Tai&#x2019;an Central Hospital, Tai&#x2019;an, Shandong, China</affiliation>
      </Author>
      <Author>
        <FirstName>Junshan</FirstName>
        <LastName>LI</LastName>
        <affiliation locale="en_US">Dept. of Gastroenterology, Tai&#x2019;an Central Hospital, Tai&#x2019;an, Shandong, China</affiliation>
      </Author>
      <Author>
        <FirstName>Ling</FirstName>
        <LastName>WANG</LastName>
        <affiliation locale="en_US">Dept. of Hematology, Tai&#x2019;an Central Hospital, Tai&#x2019;an, Shandong, China</affiliation>
      </Author>
      <Author>
        <FirstName>Hongzhi</FirstName>
        <LastName>XU</LastName>
        <affiliation locale="en_US">Dept. of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>09</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>09</Month>
        <Day>27</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Coffee is implicated in the susceptibility to several cancers. However, the association between coffee and lymphoma remains unclear. This meta-analysis aimed to assess quantitatively the association between coffee and the incidence of lymphoma.

Methods: A literature search was performed for cohort and case-control studies published using PubMed, Cochrane, and EMBASE databases. Studies were included if they reported relative ratios (RR) and corresponding 95% confidence intervals (CIs) of lymphoma with respect to coffee consumption. Pooled relative risk (RR) and its 95% confidence interval (CI) were calculated. All P values are two tailed

Results: Seven studies met the inclusion criteria, which included three cohort and four case-control studies. Compared with did not or seldom drink coffee per day, being no significantly association between coffee and risk of lymphoma (pooled RR: 1.05, 95%CI: 0.89-1.23). In the subgroup analysis, no significant association between coffee and lymphoma risk was detected not only in different study types (cohort studies RR: 1.29; 95% CI, 0.92-1.80; case control studies RR: 0.99; 95% CI, 0.82-1.99) but also in different regions (Europe RR: 1.21; 95% CI: 0.99-1.47; USA RR: 0.85; 95% CI, 0.62-1.15; Asia RR: 1.08, 95% CI: 0.84-1.40) and coffee consumption status (&#x2265;4cups/d 1.03, 95% CI: 0.69&#x2013;1.56; &#xFF1C;4cups/d RR: 1.06, 95% CI: 0.89- 1.26 ). The funnel plot revealed no evidence for publication bias.

Conclusion: There was no suf&#xFB01;cient evidence to support coffee consumption association with the risk of lymphoma. Further well-designed large-scaled cohort studies are needed to provide conclusions that are more definitive.

&#xA0;

&#xA0;</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/7848</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/7848/5547</pdf_url>
  </Article>
</Articles>
